Approaches to Improve the Surveillance, Monitoring, and Management of Noncommunicable Diseases in HIV-Infected Persons: Viewpoint

Overview

Journal JMIR Public Health Surveill

Publisher JMIR Publications

Date 2018 Dec 22

PMID 30573446

Citations 10

Authors

Pragna Patel

Keith Sabin

Peter Godfrey-Faussett

Affiliations

Soon will be listed here.

Abstract

Low-income and middle-income countries (LMICs) are undergoing an epidemiological transition, in which the burden of noncommunicable diseases (NCDs) is rising and mortality will shift from infectious diseases to NCDs. Specifically, cardiovascular disease, diabetes, renal diseases, chronic respiratory diseases, and cancer are becoming more prevalent. In some regions, particularly sub-Saharan Africa, the dual HIV and NCD epidemics will pose challenges because their joint burden will have adverse effects on the quality of life and will likely increase global inequities. Given the austere clinical infrastructure in many LMICs, innovative models of care delivery are needed to provide comprehensive care in resource-limited settings. Improved data collection and surveillance of NCDs among HIV-infected persons in LMICs are necessary to inform integrated NCD-HIV prevention, care, and treatment models that are effective across a range of geographic settings. These efforts will preserve the considerable investments that have been made to prevent the number of lives lost to HIV, promote healthy aging of persons living with HIV, and contribute to meeting United Nations Sustainable Development Goals.

Citing Articles

Incidence, risk factors for metabolic syndrome and health systems capacity for its management amongst people living with HIV, Accra-Ghana: A study protocol.

Odikro M, Torpey K, Lartey M, Puplampu P, Painstil E, Kenu E PLoS One. 2024; 19(11):e0312446.

PMID: 39499696 PMC: 11537393. DOI: 10.1371/journal.pone.0312446.

Prediction of Multimorbidity in Brazil: Latest Fifth of a Century Population Study.

Li X, Huang H, Lu Y, Stafford R, Lima S, Mota C JMIR Public Health Surveill. 2023; 9:e44647.

PMID: 37252771 PMC: 10265407. DOI: 10.2196/44647.

Preventing cardiovascular disease in midlife women with HIV: An examination of facilitators and barriers to heart health behaviors.

Stanton A, Goodman G, Robbins G, Looby S, Williams M, Psaros C J Women Aging. 2022; 35(3):223-242.

PMID: 35201972 PMC: 9399314. DOI: 10.1080/08952841.2022.2030203.

An expanded HIV care cascade: ART uptake, viral load suppression and comorbidity monitoring among adults living with HIV in Asia.

Bijker R, Kumarasamy N, Kiertiburanakul S, Pujari S, Ng O, Sun L Antivir Ther. 2021; 25(5):275-285.

PMID: 33464222 PMC: 8272912. DOI: 10.3851/IMP3379.

Cardiovascular risk and D-dimer levels in HIV-infected ART-naïve Africans.

Mocumbi A, Dobe I, Candido S, Kim N Cardiovasc Diagn Ther. 2020; 10(3):526-533.

PMID: 32695632 PMC: 7369281. DOI: 10.21037/cdt.2019.12.02.

References

Ciesla J, Roberts J . Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001; 158(5):725-30. DOI: 10.1176/appi.ajp.158.5.725. View

Bing E, Burnam M, Longshore D, Fleishman J, Sherbourne C, London A . Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001; 58(8):721-8. DOI: 10.1001/archpsyc.58.8.721. View

Bodenheimer T, Wagner E, Grumbach K . Improving primary care for patients with chronic illness. JAMA. 2002; 288(14):1775-9. DOI: 10.1001/jama.288.14.1775. View

Holmberg S, Moorman A, Williamson J, Tong T, Ward D, Wood K . Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet. 2002; 360(9347):1747-8. DOI: 10.1016/S0140-6736(02)11672-2. View

Saves M, Chene G, Ducimetiere P, Leport C, Le Moal G, Amouyel P . Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis. 2003; 37(2):292-8. DOI: 10.1086/375844. View

Carr A . HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS. 2003; 17 Suppl 1:S141-8. View

Grinspoon S, Carr A . Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005; 352(1):48-62. DOI: 10.1056/NEJMra041811. View

Briggs C, Garner P . Strategies for integrating primary health services in middle- and low-income countries at the point of delivery. Cochrane Database Syst Rev. 2006; (2):CD003318. DOI: 10.1002/14651858.CD003318.pub2. View

Lau B, Gange S, Moore R . Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. J Acquir Immune Defic Syndr. 2006; 44(2):179-87. DOI: 10.1097/01.qai.0000247229.68246.c5. View

10.

Hessol N, Kalinowski A, Benning L, Mullen J, Young M, Palella F . Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. Clin Infect Dis. 2006; 44(2):287-94. DOI: 10.1086/510488. View

11.

Friis-Moller N, Reiss P, Sabin C, Weber R, Monforte A, El-Sadr W . Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007; 356(17):1723-35. DOI: 10.1056/NEJMoa062744. View

12.

Anastos K, Lu D, Shi Q, Tien P, Kaplan R, Hessol N . Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. J Acquir Immune Defic Syndr. 2007; 45(1):34-42. DOI: 10.1097/QAI.0b013e318042d5fe. View

13.

Wand H, Calmy A, Carey D, Samaras K, Carr A, Law M . Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS. 2007; 21(18):2445-53. DOI: 10.1097/QAD.0b013e3282efad32. View

14.

Janssens B, Van Damme W, Raleigh B, Gupta J, Khem S, Soy Ty K . Offering integrated care for HIV/AIDS, diabetes and hypertension within chronic disease clinics in Cambodia. Bull World Health Organ. 2007; 85(11):880-5. PMC: 2636263. DOI: 10.2471/blt.06.036574. View

15.

Goulet J, Fultz S, Rimland D, Butt A, Gibert C, Rodriguez-Barradas M . Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity?. Clin Infect Dis. 2008; 45(12):1593-601. PMC: 3687553. DOI: 10.1086/523577. View

16.

Patel P, Hanson D, Sullivan P, Novak R, Moorman A, Tong T . Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008; 148(10):728-36. DOI: 10.7326/0003-4819-148-10-200805200-00005. View

17.

Harries A, Jahn A, Zachariah R, Enarson D . Adapting the DOTS framework for tuberculosis control to the management of non-communicable diseases in sub-Saharan Africa. PLoS Med. 2008; 5(6):e124. PMC: 3280072. DOI: 10.1371/journal.pmed.0050124. View

18.

Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson A, Lambert P . Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008; 300(1):51-9. DOI: 10.1001/jama.300.1.51. View

19.

. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008; 372(9635):293-9. PMC: 3130543. DOI: 10.1016/S0140-6736(08)61113-7. View

20.

Kingsley L, Cuervo-Rojas J, Munoz A, Palella F, Post W, Witt M . Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study. AIDS. 2008; 22(13):1589-99. PMC: 3633463. DOI: 10.1097/QAD.0b013e328306a6c5. View